BPC‑157, also known as Body Protective Compound‑157, is a 15‑amino‑acid peptide naturally found in gastric secretions. Dr. Jason Schuster explains that this synthetic copy of the body’s own molecule is being touted for its remarkable healing potential, even as regulatory agencies seek to restrict its use.
A gut‑derived peptide
According to Dr. Schuster, BPC‑157 is a pentadecapeptide—meaning it contains 15 amino acids—that originates from the stomach’s gastric juices. The version sold as a supplement is a laboratory‑synthesized formulation that mirrors the exact molecular structure of the naturally occurring compound in our gut microbiome.
- 15‑amino‑acid pentadecapeptide
- Naturally present in gastric secretions
- Synthesized in a lab to match the endogenous molecule
How it promotes healing
Dr. Schuster notes that BPC‑157 appears to up‑regulate vascular endothelial growth factor (VEGF), driving angiogenesis and tissue regeneration. In animal studies the peptide has been shown to stimulate nerve regrowth after spinal‑cord injury and to support overall cellular repair, offering effects similar to human growth hormone but without the reported adverse outcomes.
- Increases VEGF, fostering new blood‑vessel formation
- Enhances angiogenesis and tissue repair pathways
- Supports neuronal regrowth in spinal‑cord injury models
Potential health impacts
The video highlights a range of therapeutic possibilities for BPC‑157, from accelerated wound healing to improved recovery from concussions and other neuro‑traumas. Dr. Schuster also mentions emerging data suggesting anti‑cancer effects, though he cautions that the same VEGF boost could theoretically aid tumor growth in individuals with active cancer.
- Rapid wound and tissue healing
- Improved recovery from concussions and spinal injuries
- Anti‑inflammatory properties
- Potential anti‑cancer activity in pre‑clinical studies
- Comparable to growth hormone without known negative side‑effects
Typical protocol and cautions
Dr. Schuster describes the current dosing regimen as a sub‑cutaneous injection of 5 mg, administered two to three times per week on an eight‑week‑on, eight‑week‑off schedule. He emphasizes the extraordinarily high safety margin—the lethal dose in animal studies is about 2 g per kilogram, roughly 27,000 times the therapeutic amount. Nonetheless, he advises extra caution for anyone with active cancer and stresses the importance of sourcing the peptide from reputable suppliers.
- 5 mg sub‑cutaneous injection per session
- 2–3 times per week, 8 weeks on / 8 weeks off
- Lethal dose ≈2 g/kg (≈136 g for a 150‑lb adult) – 27,000× typical dose
- Avoid use in active cancer without medical oversight
- Obtain from trusted, quality‑controlled vendors
“BPC‑157 is one of the safest and most effective peptides out there, with a lethal dose that is over twenty‑seven thousand times higher than the typical therapeutic dose.”— Dr. Jason Schuster
Dr. Schuster's short takes on this topic — tap to play.
Go deeper than the summary
Dr. Schuster's accredited courses on supplementation, epigenetics, and peptide therapy — the full research, dosing, and video breakdowns.